Lisa Bancroft is among thousands of people who have been tested for the faulty BRCA gene since its discovery 30 years ago.

The IDEAL team will test this new model on targets known to be relevant in ovarian cancer, the deadliest of gynecologic ...

Pregnancy complicates a cancer diagnosis in many ways. So cancer treatment may need to be adjusted. Here’s what we know so ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

A University of Iowa researcher is using federal funding to develop a new approach to combat ovarian cancer. According to the ...

The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...

Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...

In this excerpt from "Too Young for Cancer," Katie Coleman describes receiving her cancer diagnosis after years of having her symptoms misdiagnosed.

Pegylated liposomal doxorubicin (PLD) has demonstrated safety and efficacy in patients with partially platinum-sensitive, ...

Academy Award-winning actress Kathy Bates recently shared insights into her personal journey with breast cancer and her ...